Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Envveno Medical Corp (NVNO) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Envveno Medical Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1661053.
Total stock buying since 2019: $246,092.
Total stock sales since 2019: $1,372,025.
Total stock option exercises since 2019: $29,919.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 12,000 | $30,599 | 8,334 | $51,837 | 8,334 | $29,919 |
| 2022 | 11,251 | $60,941 | 0 | $0 | 6,246 | $0 |
| 2021 | 21,392 | $129,552 | 0 | $0 | 2,472 | $0 |
| 2020 | 0 | $0 | 2,175,583 | $861,364 | 0 | $0 |
| 2019 | 21,740 | $25,000 | 684,813 | $458,824 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 12,000 | $30,599 | 0 | $0 | 0 | $0 |
| 2024-03 | 0 | $0 | 8,334 | $51,837 | 8,334 | $29,919 |
| 2022-09 | 0 | $0 | 0 | $0 | 6,246 | $0 |
| 2022-08 | 7,751 | $47,591 | 0 | $0 | 0 | $0 |
| 2022-06 | 3,500 | $13,350 | 0 | $0 | 0 | $0 |
| 2021-11 | 4,000 | $30,600 | 0 | $0 | 388 | $0 |
| 2021-09 | 0 | $0 | 0 | $0 | 2,084 | $0 |
| 2021-08 | 1,300 | $10,010 | 0 | $0 | 0 | $0 |
| 2021-06 | 2,000 | $12,500 | 0 | $0 | 0 | $0 |
| 2021-05 | 14,092 | $76,442 | 0 | $0 | 0 | $0 |
| 2020-08 | 0 | $0 | 370,000 | $118,650 | 0 | $0 |
| 2020-07 | 0 | $0 | 438,450 | $177,115 | 0 | $0 |
| 2020-06 | 0 | $0 | 1,367,133 | $565,599 | 0 | $0 |
| 2019-06 | 0 | $0 | 684,813 | $458,824 | 0 | $0 |
| 2019-03 | 21,740 | $25,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-19 | Berman Robert Andrew (Chief Executive Officer) | Buy | 12,000 | 2.55 | 30,599 |
| 2024-03-13 | Alavi Hamed (Chief Technology Officer) | Sale | 8,334 | 6.22 | 51,837 |
| 2024-03-13 | Alavi Hamed (Chief Technology Officer) | Option Ex | 8,334 | 3.59 | 29,919 |
| 2022-09-13 | Gray Robert | Option Ex | 2,082 | .00 | 0 |
| 2022-09-13 | Jenusaitis Matthew | Option Ex | 2,082 | .00 | 0 |
| 2022-08-16 | Duhay Francis | Buy | 7,751 | 6.14 | 47,591 |
| 2022-06-30 | Shrivastava Sanjay | Buy | 1,000 | 3.85 | 3,850 |
| 2022-06-27 | Berman Robert Andrew (Chief Executive Officer) | Buy | 2,500 | 3.80 | 9,500 |
| 2021-11-19 | Berman Robert Andrew (CEO) | Buy | 2,000 | 7.43 | 14,860 |
| 2021-11-16 | Shrivastava Sanjay | Option Ex | 388 | .00 | 0 |
| 2021-11-16 | Berman Robert Andrew (CEO) | Buy | 2,000 | 7.87 | 15,740 |
| 2021-09-13 | Gray Robert | Option Ex | 1,042 | .00 | 0 |
| 2021-09-13 | Jenusaitis Matthew | Option Ex | 1,042 | .00 | 0 |
| 2021-08-25 | Jenusaitis Matthew | Buy | 1,300 | 7.70 | 10,010 |
| 2021-06-16 | Gray Robert | Buy | 2,000 | 6.25 | 12,500 |
| 2021-05-21 | Glickman Marc H. (SVP & Chief Medical Officer) | Buy | 1,600 | 5.90 | 9,440 |
| 2021-05-18 | Berman Robert Andrew (Chief Executive Officer) | Buy | 3,000 | 5.47 | 16,410 |
| 2021-05-17 | Duhay Francis | Buy | 9,492 | 5.33 | 50,592 |
| 2020-08-21 | Biodyne Holding, S.a. | Sale | 75,000 | .38 | 28,500 |
| 2020-08-20 | Biodyne Holding, S.a. | Sale | 75,000 | .27 | 20,250 |
| 2020-08-19 | Biodyne Holding, S.a. | Sale | 50,000 | .30 | 15,000 |
| 2020-08-18 | Biodyne Holding, S.a. | Sale | 50,000 | .34 | 17,000 |
| 2020-08-14 | Biodyne Holding, S.a. | Sale | 50,000 | .31 | 15,500 |
| 2020-08-03 | Biodyne Holding, S.a. | Sale | 70,000 | .32 | 22,400 |
| 2020-07-31 | Biodyne Holding, S.a. | Sale | 5,000 | .34 | 1,700 |
| 2020-07-30 | Biodyne Holding, S.a. | Sale | 25,000 | .32 | 8,000 |
| 2020-07-21 | Biodyne Holding, S.a. | Sale | 50,000 | .45 | 22,500 |
| 2020-07-20 | Biodyne Holding, S.a. | Sale | 150,000 | .43 | 64,500 |
| 2020-07-17 | Biodyne Holding, S.a. | Sale | 50,000 | .38 | 19,000 |
| 2020-07-16 | Biodyne Holding, S.a. | Sale | 50,000 | .38 | 19,000 |
| 2020-07-06 | Biodyne Holding, S.a. | Sale | 6,450 | .39 | 2,515 |
| 2020-07-02 | Biodyne Holding, S.a. | Sale | 57,000 | .40 | 22,800 |
| 2020-07-01 | Biodyne Holding, S.a. | Sale | 45,000 | .38 | 17,100 |
| 2020-06-29 | Biodyne Holding, S.a. | Sale | 68,094 | .39 | 26,556 |
| 2020-06-26 | Biodyne Holding, S.a. | Sale | 80,000 | .38 | 30,400 |
| 2020-06-25 | Biodyne Holding, S.a. | Sale | 100,000 | .40 | 40,000 |
| 2020-06-24 | Biodyne Holding, S.a. | Sale | 55,530 | .42 | 23,322 |
| 2020-06-23 | Biodyne Holding, S.a. | Sale | 80,000 | .43 | 34,400 |
| 2020-06-22 | Biodyne Holding, S.a. | Sale | 63,186 | .46 | 29,065 |
| 2020-06-19 | Biodyne Holding, S.a. | Sale | 80,000 | .46 | 36,800 |
| 2020-06-18 | Biodyne Holding, S.a. | Sale | 61,640 | .45 | 27,738 |
| 2020-06-17 | Biodyne Holding, S.a. | Sale | 203,100 | .48 | 97,488 |
| 2020-06-16 | Biodyne Holding, S.a. | Sale | 150,000 | .43 | 64,500 |
| 2020-06-15 | Biodyne Holding, S.a. | Sale | 100,000 | .42 | 42,000 |
| 2020-06-11 | Biodyne Holding, S.a. | Sale | 100,000 | .39 | 39,000 |
| 2020-06-03 | Biodyne Holding, S.a. | Sale | 5,583 | .31 | 1,730 |
| 2020-06-02 | Biodyne Holding, S.a. | Sale | 220,000 | .33 | 72,600 |
| 2019-06-07 | Biodyne Holding, S.a. | Sale | 684,813 | .67 | 458,824 |
| 2019-03-12 | Berman Robert Andrew (Chief Executive Officer) | Buy | 21,740 | 1.15 | 25,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVNO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Envveno Medical Corp (symbol NVNO, CIK number 1661053) see the Securities and Exchange Commission (SEC) website.